| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gaucher Disease | 40 | 2021 | 43 | 4.290 |
Why?
|
| Glucosylceramidase | 34 | 2017 | 39 | 2.290 |
Why?
|
| Bipolar Disorder | 9 | 2014 | 254 | 1.000 |
Why?
|
| Glucosidases | 15 | 1988 | 15 | 0.750 |
Why?
|
| Parkinson Disease | 5 | 2017 | 97 | 0.740 |
Why?
|
| Ellis-Van Creveld Syndrome | 2 | 2014 | 11 | 0.690 |
Why?
|
| Genetic Linkage | 10 | 2005 | 101 | 0.640 |
Why?
|
| alpha-Synuclein | 2 | 2017 | 20 | 0.590 |
Why?
|
| Corpus Striatum | 3 | 2013 | 96 | 0.530 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 113 | 0.440 |
Why?
|
| Jews | 4 | 2002 | 14 | 0.410 |
Why?
|
| Synapses | 1 | 2013 | 177 | 0.400 |
Why?
|
| Schizophrenia | 6 | 2010 | 256 | 0.390 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 6 | 0.350 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 34 | 0.340 |
Why?
|
| Dog Diseases | 1 | 2010 | 55 | 0.320 |
Why?
|
| Humans | 83 | 2021 | 59284 | 0.310 |
Why?
|
| Chromosome Mapping | 10 | 1999 | 294 | 0.310 |
Why?
|
| Embryonic and Fetal Development | 2 | 2000 | 47 | 0.300 |
Why?
|
| Intellectual Disability | 4 | 2018 | 168 | 0.290 |
Why?
|
| Disease Models, Animal | 7 | 2017 | 2061 | 0.290 |
Why?
|
| Genotype | 15 | 2013 | 644 | 0.280 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2004 | 22 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 677 | 0.270 |
Why?
|
| Polymorphism, Genetic | 3 | 1998 | 197 | 0.250 |
Why?
|
| Proteins | 5 | 2002 | 742 | 0.250 |
Why?
|
| DNA, Recombinant | 2 | 2004 | 45 | 0.250 |
Why?
|
| Animals | 36 | 2017 | 19595 | 0.240 |
Why?
|
| Mice | 23 | 2017 | 10249 | 0.240 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2004 | 2 | 0.240 |
Why?
|
| Entorhinal Cortex | 1 | 2004 | 8 | 0.240 |
Why?
|
| Pedigree | 7 | 2014 | 190 | 0.230 |
Why?
|
| Trinucleotide Repeats | 3 | 1998 | 20 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2000 | 24 | 0.230 |
Why?
|
| Sphingosine | 2 | 2002 | 22 | 0.230 |
Why?
|
| Reward | 1 | 2004 | 82 | 0.220 |
Why?
|
| Male | 37 | 2019 | 27480 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2005 | 16 | 0.220 |
Why?
|
| Prefrontal Cortex | 3 | 2016 | 112 | 0.220 |
Why?
|
| DNA Mutational Analysis | 6 | 2013 | 195 | 0.210 |
Why?
|
| Learning | 1 | 2004 | 171 | 0.210 |
Why?
|
| Lactation | 3 | 1998 | 70 | 0.200 |
Why?
|
| Oxytocin | 3 | 1998 | 49 | 0.200 |
Why?
|
| Base Sequence | 12 | 1998 | 1311 | 0.200 |
Why?
|
| Genetic Markers | 5 | 1998 | 121 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 4 | 2018 | 396 | 0.200 |
Why?
|
| Phenotype | 13 | 2013 | 1155 | 0.200 |
Why?
|
| Child | 21 | 2011 | 4298 | 0.190 |
Why?
|
| Lysosomes | 5 | 2016 | 162 | 0.190 |
Why?
|
| Israel | 1 | 2021 | 18 | 0.190 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2021 | 15 | 0.190 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 18 | 0.180 |
Why?
|
| Karyotyping | 2 | 2018 | 45 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2000 | 13 | 0.180 |
Why?
|
| Molecular Sequence Data | 12 | 1998 | 1977 | 0.180 |
Why?
|
| Australia | 1 | 2021 | 93 | 0.180 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 64 | 0.180 |
Why?
|
| Female | 31 | 2019 | 30798 | 0.180 |
Why?
|
| Mutation | 8 | 2017 | 2425 | 0.170 |
Why?
|
| Labor, Obstetric | 2 | 1998 | 41 | 0.170 |
Why?
|
| Pseudogenes | 4 | 1999 | 16 | 0.170 |
Why?
|
| Pennsylvania | 3 | 2014 | 56 | 0.160 |
Why?
|
| Cosmids | 2 | 1998 | 9 | 0.160 |
Why?
|
| Amino Acid Sequence | 11 | 1998 | 1580 | 0.160 |
Why?
|
| DNA | 8 | 2000 | 789 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 135 | 0.160 |
Why?
|
| Infant | 10 | 2016 | 1527 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 23 | 0.150 |
Why?
|
| X Chromosome | 1 | 1998 | 44 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2000 | 167 | 0.150 |
Why?
|
| Adolescent | 17 | 2016 | 5914 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 189 | 0.150 |
Why?
|
| Genetic Techniques | 1 | 1998 | 40 | 0.150 |
Why?
|
| Point Mutation | 3 | 1999 | 162 | 0.150 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 16 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2018 | 58 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 166 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2019 | 353 | 0.150 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 1999 | 28 | 0.150 |
Why?
|
| Chromosomes, Human | 1 | 2018 | 54 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 128 | 0.140 |
Why?
|
| MicroRNAs | 3 | 2013 | 617 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 186 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 198 | 0.140 |
Why?
|
| Adult | 18 | 2016 | 15729 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 120 | 0.140 |
Why?
|
| Child, Preschool | 11 | 2011 | 1837 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 116 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 250 | 0.130 |
Why?
|
| Protein Sorting Signals | 2 | 1987 | 57 | 0.130 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2016 | 2 | 0.130 |
Why?
|
| RNA, Messenger | 7 | 1998 | 1470 | 0.130 |
Why?
|
| Fertilization | 1 | 1996 | 81 | 0.130 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 261 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2009 | 23 | 0.130 |
Why?
|
| Genetic Variation | 1 | 1998 | 367 | 0.130 |
Why?
|
| Retroviridae | 2 | 1986 | 73 | 0.130 |
Why?
|
| Saccades | 2 | 1994 | 16 | 0.130 |
Why?
|
| Mental Health | 1 | 1998 | 348 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 3 | 2010 | 90 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2000 | 500 | 0.130 |
Why?
|
| Cells, Cultured | 8 | 2016 | 2102 | 0.130 |
Why?
|
| Leukocytes | 4 | 1984 | 108 | 0.120 |
Why?
|
| Epidermis | 2 | 2011 | 37 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2016 | 214 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 1991 | 14 | 0.120 |
Why?
|
| Cell Line | 11 | 2009 | 2014 | 0.120 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 1991 | 36 | 0.120 |
Why?
|
| Membrane Glycoproteins | 2 | 1995 | 669 | 0.120 |
Why?
|
| Inositol | 2 | 2013 | 10 | 0.120 |
Why?
|
| Alleles | 6 | 1999 | 425 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 2 | 1986 | 133 | 0.120 |
Why?
|
| Amish | 1 | 2014 | 11 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2013 | 179 | 0.120 |
Why?
|
| Brain | 8 | 2017 | 1487 | 0.120 |
Why?
|
| Neurons | 3 | 2016 | 856 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2016 | 274 | 0.110 |
Why?
|
| Evoked Potentials, Motor | 1 | 2013 | 21 | 0.110 |
Why?
|
| Heterozygote | 3 | 2017 | 168 | 0.110 |
Why?
|
| Mice, Knockout | 7 | 2017 | 1987 | 0.110 |
Why?
|
| Middle Aged | 10 | 2019 | 16232 | 0.110 |
Why?
|
| Models, Biological | 2 | 2016 | 1138 | 0.110 |
Why?
|
| Dopamine | 1 | 2013 | 101 | 0.110 |
Why?
|
| Nerve Growth Factors | 2 | 2010 | 28 | 0.110 |
Why?
|
| Tourette Syndrome | 1 | 2013 | 12 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 350 | 0.100 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2013 | 33 | 0.100 |
Why?
|
| Cadherins | 1 | 2013 | 67 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 150 | 0.100 |
Why?
|
| Transfection | 3 | 2013 | 673 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 140 | 0.100 |
Why?
|
| Ocular Motility Disorders | 1 | 1992 | 3 | 0.100 |
Why?
|
| Fibroblasts | 8 | 1991 | 367 | 0.100 |
Why?
|
| Glucosylceramides | 4 | 2017 | 4 | 0.100 |
Why?
|
| Psychosine | 3 | 2017 | 3 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2013 | 343 | 0.090 |
Why?
|
| Genetic Therapy | 2 | 2006 | 734 | 0.090 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1991 | 14 | 0.090 |
Why?
|
| Isoenzymes | 2 | 1982 | 134 | 0.090 |
Why?
|
| G(M1) Ganglioside | 2 | 1980 | 9 | 0.090 |
Why?
|
| Genetic Vectors | 2 | 1988 | 813 | 0.090 |
Why?
|
| Gangliosides | 2 | 1980 | 19 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 3185 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2000 | 155 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 47 | 0.090 |
Why?
|
| Antipsychotic Agents | 2 | 2010 | 312 | 0.090 |
Why?
|
| Transplantation, Heterotopic | 1 | 1990 | 7 | 0.090 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2010 | 7 | 0.090 |
Why?
|
| Models, Genetic | 3 | 1997 | 253 | 0.090 |
Why?
|
| Ethacrynic Acid | 1 | 2009 | 2 | 0.090 |
Why?
|
| S100 Proteins | 1 | 2010 | 21 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1989 | 8 | 0.080 |
Why?
|
| Nevus, Pigmented | 1 | 1989 | 20 | 0.080 |
Why?
|
| Schizophrenia, Childhood | 2 | 1999 | 23 | 0.080 |
Why?
|
| Genes | 2 | 1986 | 96 | 0.080 |
Why?
|
| Dogs | 1 | 2010 | 316 | 0.080 |
Why?
|
| Thrombospondins | 3 | 1998 | 9 | 0.080 |
Why?
|
| Insect Viruses | 1 | 1988 | 2 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 79 | 0.080 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1988 | 7 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 1988 | 55 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 324 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 338 | 0.070 |
Why?
|
| Galactosidases | 1 | 1987 | 3 | 0.070 |
Why?
|
| alpha-Galactosidase | 1 | 1987 | 8 | 0.070 |
Why?
|
| Rats | 8 | 2016 | 1907 | 0.070 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1988 | 21 | 0.070 |
Why?
|
| Hydrops Fetalis | 2 | 2000 | 3 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1100 | 0.070 |
Why?
|
| Glycosphingolipids | 1 | 2006 | 10 | 0.070 |
Why?
|
| Genetic Heterogeneity | 2 | 2005 | 23 | 0.070 |
Why?
|
| Aged | 4 | 2019 | 13285 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 75 | 0.070 |
Why?
|
| Gene Targeting | 2 | 2004 | 82 | 0.070 |
Why?
|
| Trypsin | 2 | 1976 | 41 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2010 | 891 | 0.060 |
Why?
|
| Molecular Weight | 5 | 1987 | 187 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1989 | 104 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 1986 | 112 | 0.060 |
Why?
|
| Exons | 4 | 1998 | 193 | 0.060 |
Why?
|
| Autoradiography | 1 | 2004 | 53 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 659 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2004 | 90 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 4 | 1997 | 13 | 0.060 |
Why?
|
| Cues | 1 | 2004 | 76 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 1989 | 403 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2002 | 198 | 0.060 |
Why?
|
| Age of Onset | 3 | 2017 | 173 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2004 | 247 | 0.050 |
Why?
|
| Pregnancy | 6 | 2011 | 2352 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 1220 | 0.050 |
Why?
|
| DNA, Complementary | 4 | 1997 | 166 | 0.050 |
Why?
|
| Reference Values | 3 | 1998 | 323 | 0.050 |
Why?
|
| Aspartylglucosaminuria | 2 | 1998 | 2 | 0.050 |
Why?
|
| Microscopy, Electron | 5 | 2011 | 252 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2013 | 595 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1536 | 0.050 |
Why?
|
| Lod Score | 2 | 2005 | 26 | 0.050 |
Why?
|
| Aspartylglucosylaminase | 2 | 1998 | 2 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 158 | 0.050 |
Why?
|
| Contig Mapping | 1 | 2000 | 4 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2000 | 7 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 1998 | 171 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2018 | 64 | 0.050 |
Why?
|
| Ophthalmoplegia | 1 | 2000 | 4 | 0.050 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 42 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 895 | 0.050 |
Why?
|
| Supraoptic Nucleus | 2 | 1998 | 4 | 0.040 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 1998 | 22 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2000 | 43 | 0.040 |
Why?
|
| Pituitary Gland, Posterior | 2 | 1998 | 19 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2020 | 22 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1993 | 385 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 304 | 0.040 |
Why?
|
| Receptors, GABA-A | 2 | 1991 | 26 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2002 | 178 | 0.040 |
Why?
|
| Gestational Age | 1 | 2000 | 182 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 1996 | 847 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 119 | 0.040 |
Why?
|
| Founder Effect | 1 | 1999 | 11 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 221 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 2323 | 0.040 |
Why?
|
| Christianity | 1 | 1998 | 4 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 73 | 0.040 |
Why?
|
| tau Proteins | 1 | 2019 | 103 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1998 | 75 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1999 | 33 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 99 | 0.040 |
Why?
|
| Finland | 1 | 1998 | 20 | 0.040 |
Why?
|
| Young Adult | 3 | 2016 | 4318 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 159 | 0.040 |
Why?
|
| Hemorrhagic Disorders | 1 | 1998 | 1 | 0.040 |
Why?
|
| Skin | 3 | 1996 | 350 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 1998 | 11 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 11 | 0.040 |
Why?
|
| Splenectomy | 1 | 1998 | 41 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 1998 | 39 | 0.040 |
Why?
|
| Connective Tissue | 1 | 1998 | 12 | 0.040 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1998 | 14 | 0.040 |
Why?
|
| beta-Glucosidase | 1 | 2017 | 3 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 99 | 0.040 |
Why?
|
| HLA Antigens | 1 | 1998 | 59 | 0.040 |
Why?
|
| Europe | 1 | 1998 | 182 | 0.040 |
Why?
|
| California | 1 | 1998 | 160 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 50 | 0.040 |
Why?
|
| Child Behavior | 1 | 1998 | 69 | 0.040 |
Why?
|
| Fragile X Syndrome | 1 | 1998 | 28 | 0.040 |
Why?
|
| DNA Primers | 2 | 1996 | 291 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 65 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 1998 | 151 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 357 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1998 | 290 | 0.040 |
Why?
|
| Placenta | 3 | 1982 | 60 | 0.040 |
Why?
|
| Collagen | 1 | 1998 | 121 | 0.040 |
Why?
|
| Twin Studies as Topic | 1 | 1997 | 15 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 1997 | 79 | 0.040 |
Why?
|
| Transgenes | 1 | 2017 | 175 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2018 | 133 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1987 | 19 | 0.030 |
Why?
|
| Central Nervous System | 1 | 1998 | 191 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1093 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1998 | 298 | 0.030 |
Why?
|
| Homozygote | 1 | 1996 | 117 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 287 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2016 | 16 | 0.030 |
Why?
|
| Barbados | 1 | 2016 | 1 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1996 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1996 | 6 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 1998 | 846 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1996 | 16 | 0.030 |
Why?
|
| Dementia | 1 | 2019 | 247 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 97 | 0.030 |
Why?
|
| Cell Separation | 1 | 1976 | 149 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 1995 | 21 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1995 | 21 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 53 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 321 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 606 | 0.030 |
Why?
|
| Peptides | 1 | 1999 | 548 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 152 | 0.030 |
Why?
|
| Nucleotides | 1 | 1995 | 41 | 0.030 |
Why?
|
| Fluorescence | 1 | 1995 | 84 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1205 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 287 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2009 | 194 | 0.030 |
Why?
|
| Glycoproteins | 2 | 1993 | 193 | 0.030 |
Why?
|
| Prevalence | 1 | 1998 | 1279 | 0.030 |
Why?
|
| Genome, Human | 1 | 1996 | 219 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 549 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 1992 | 1311 | 0.030 |
Why?
|
| Immunochemistry | 3 | 1988 | 11 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 1993 | 693 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1993 | 70 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1907 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 827 | 0.030 |
Why?
|
| Ichthyosis | 1 | 1992 | 8 | 0.030 |
Why?
|
| Calcium | 1 | 2016 | 552 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1058 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1993 | 527 | 0.030 |
Why?
|
| Liver | 3 | 2002 | 783 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1992 | 230 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1991 | 253 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1992 | 34 | 0.020 |
Why?
|
| Monocytes | 2 | 1986 | 351 | 0.020 |
Why?
|
| Introns | 3 | 1998 | 106 | 0.020 |
Why?
|
| Hippocampus | 2 | 2010 | 238 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 384 | 0.020 |
Why?
|
| RNA | 3 | 2009 | 403 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 1991 | 6 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1991 | 6 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 1991 | 15 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 39 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1992 | 136 | 0.020 |
Why?
|
| Mental Disorders | 1 | 1998 | 763 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 571 | 0.020 |
Why?
|
| Anemia | 1 | 1992 | 117 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2010 | 29 | 0.020 |
Why?
|
| Time Factors | 2 | 1995 | 3567 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 373 | 0.020 |
Why?
|
| Nuclear Family | 2 | 2001 | 19 | 0.020 |
Why?
|
| Ouabain | 1 | 2009 | 6 | 0.020 |
Why?
|
| Mucolipidoses | 2 | 1988 | 2 | 0.020 |
Why?
|
| Sodium | 1 | 2009 | 60 | 0.020 |
Why?
|
| Pheochromocytoma | 1 | 1990 | 27 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 1990 | 42 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1987 | 123 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1990 | 45 | 0.020 |
Why?
|
| Oncogenes | 1 | 1990 | 68 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 5063 | 0.020 |
Why?
|
| Potassium | 1 | 2009 | 109 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2009 | 13 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2000 | 253 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1990 | 454 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Immunoassay | 1 | 2009 | 51 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 36 | 0.020 |
Why?
|
| Risk Factors | 1 | 1998 | 4997 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 116 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1988 | 80 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1988 | 10 | 0.020 |
Why?
|
| Insecta | 1 | 1988 | 38 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1987 | 7 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1990 | 502 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 1987 | 23 | 0.020 |
Why?
|
| Isoelectric Point | 2 | 1993 | 14 | 0.020 |
Why?
|
| Glycosylation | 1 | 1988 | 134 | 0.020 |
Why?
|
| Ethanol | 1 | 1991 | 307 | 0.020 |
Why?
|
| Genetic Code | 1 | 1987 | 7 | 0.020 |
Why?
|
| Risk | 1 | 1988 | 371 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 1564 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1988 | 216 | 0.020 |
Why?
|
| Virus Activation | 1 | 1986 | 24 | 0.020 |
Why?
|
| Microbial Collagenase | 2 | 1976 | 2 | 0.020 |
Why?
|
| Oligodendroglia | 2 | 1976 | 33 | 0.020 |
Why?
|
| Chromosomes, Human, 1-3 | 1 | 1985 | 1 | 0.020 |
Why?
|
| Chymotrypsin | 2 | 1976 | 28 | 0.020 |
Why?
|
| Cricetulus | 1 | 1985 | 102 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1986 | 228 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 151 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 1998 | 2034 | 0.020 |
Why?
|
| Genes, Recessive | 2 | 1998 | 52 | 0.020 |
Why?
|
| Cricetinae | 1 | 1985 | 377 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 68 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 147 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1986 | 165 | 0.010 |
Why?
|
| Chromatin | 1 | 2009 | 594 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1984 | 174 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1986 | 274 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1982 | 11 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 374 | 0.010 |
Why?
|
| Viscera | 1 | 2000 | 11 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 485 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1980 | 2 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1980 | 56 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 1980 | 23 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1980 | 51 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 208 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1980 | 33 | 0.010 |
Why?
|
| Colorimetry | 1 | 1980 | 26 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 162 | 0.010 |
Why?
|
| Fibrosis | 1 | 2000 | 151 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 1999 | 9 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 1999 | 49 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1980 | 95 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1999 | 26 | 0.010 |
Why?
|
| Indians, North American | 1 | 1999 | 26 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1998 | 35 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 869 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 1998 | 7 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1998 | 190 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1998 | 12 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1998 | 15 | 0.010 |
Why?
|
| DiGeorge Syndrome | 1 | 1998 | 4 | 0.010 |
Why?
|
| Tail | 1 | 1998 | 7 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1998 | 20 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1998 | 27 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 14 | 0.010 |
Why?
|
| Tendons | 1 | 1998 | 20 | 0.010 |
Why?
|
| Social Isolation | 1 | 1998 | 28 | 0.010 |
Why?
|
| Maze Learning | 1 | 1998 | 51 | 0.010 |
Why?
|
| Genomic Library | 1 | 1997 | 11 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 1998 | 47 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 40 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1988 | 282 | 0.010 |
Why?
|
| Aggression | 1 | 1998 | 57 | 0.010 |
Why?
|
| Fertility | 1 | 1998 | 85 | 0.010 |
Why?
|
| Multigene Family | 1 | 1997 | 93 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1998 | 211 | 0.010 |
Why?
|
| Schools | 1 | 1998 | 156 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 113 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 336 | 0.010 |
Why?
|
| Bone Density | 1 | 1998 | 173 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 199 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 236 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1987 | 48 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1976 | 15 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 421 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 96 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1997 | 203 | 0.010 |
Why?
|
| Fetal Death | 1 | 1975 | 14 | 0.010 |
Why?
|
| Estrus | 1 | 1975 | 27 | 0.010 |
Why?
|
| Embryo Loss | 1 | 1975 | 12 | 0.010 |
Why?
|
| Pregnancy, Animal | 1 | 1975 | 10 | 0.010 |
Why?
|
| Microwaves | 1 | 1975 | 15 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1975 | 22 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 322 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 306 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2001 | 2435 | 0.010 |
Why?
|
| Parents | 1 | 1998 | 379 | 0.010 |
Why?
|
| Cyclohexenes | 1 | 1994 | 5 | 0.010 |
Why?
|
| Mice, Hairless | 1 | 1994 | 18 | 0.010 |
Why?
|
| Sphingolipids | 1 | 1994 | 22 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1976 | 397 | 0.010 |
Why?
|
| Permeability | 1 | 1994 | 47 | 0.010 |
Why?
|
| Sphingolipid Activator Proteins | 1 | 1993 | 1 | 0.010 |
Why?
|
| Saposins | 1 | 1993 | 2 | 0.010 |
Why?
|
| Disease Progression | 1 | 1998 | 1039 | 0.010 |
Why?
|
| Semen | 1 | 1993 | 42 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1997 | 709 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 1036 | 0.010 |
Why?
|
| Milk, Human | 1 | 1993 | 94 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 843 | 0.010 |
Why?
|
| Japan | 1 | 1991 | 60 | 0.010 |
Why?
|
| Membranes | 1 | 1991 | 19 | 0.010 |
Why?
|
| Poly A | 1 | 1991 | 27 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1991 | 109 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 231 | 0.010 |
Why?
|
| Genes, ras | 1 | 1989 | 28 | 0.010 |
Why?
|
| RNA Probes | 1 | 1988 | 9 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1988 | 148 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1988 | 120 | 0.000 |
Why?
|
| Thalamus | 1 | 1988 | 62 | 0.000 |
Why?
|
| Cerebellum | 1 | 1988 | 94 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1988 | 62 | 0.000 |
Why?
|
| Injections | 1 | 1987 | 79 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1998 | 5141 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1997 | 2885 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 10 | 0.000 |
Why?
|
| Leupeptins | 1 | 1987 | 16 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1988 | 475 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 56 | 0.000 |
Why?
|
| Colloids | 1 | 1987 | 49 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 255 | 0.000 |
Why?
|
| Hexosaminidases | 1 | 1985 | 7 | 0.000 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1985 | 22 | 0.000 |
Why?
|
| United States | 1 | 1999 | 7492 | 0.000 |
Why?
|
| alpha-Glucosidases | 1 | 1985 | 16 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1985 | 64 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1988 | 861 | 0.000 |
Why?
|
| Insulin | 1 | 1989 | 687 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1985 | 219 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1985 | 167 | 0.000 |
Why?
|
| Gold | 1 | 1987 | 227 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1983 | 182 | 0.000 |
Why?
|
| Epitopes | 1 | 1983 | 298 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1983 | 880 | 0.000 |
Why?
|
| Protein Binding | 1 | 1983 | 1545 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1975 | 183 | 0.000 |
Why?
|